KIF18A and neoplasm: In addition, many researchers have reported that KIF18A is a potential therapeutic target and prognostic factor for a variety of tumours, including hepatocellular carcinoma, prostate cancer, and lung adenocarcinoma (Luo et al., 2018; Zhang et al., 2019; Zhong et al., 2019).